| Affected Systems |
|
|
|
|
|
|
|
|
|
|
|
cardiovascular system
|
|
|
|
√
|
√
|
√
|
|
|
|
|
abnormal cardiovascular development
|
|
|
|
|
|
√
|
|
|
|
|
abnormal heart layer morphology
|
|
|
|
√
|
√
|
√
|
|
|
|
|
thin myocardium
|
|
|
|
|
|
√
|
|
|
|
|
thin ventricular wall
|
|
|
|
|
|
√
|
|
|
|
|
decreased fetal cardiomyocyte proliferation
|
|
|
|
|
|
√
|
|
|
|
cellular
|
|
|
|
|
|
√
|
|
|
|
|
decreased fetal cardiomyocyte proliferation
|
|
|
|
|
|
√
|
|
|
|
limbs/digits/tail
|
|
|
|
|
|
√
|
√
|
√
|
√
|
|
hindlimb oligodactyly
|
|
|
|
|
|
|
|
|
√
|
|
polydactyly
|
|
|
|
|
|
√
|
√
|
|
|
|
preaxial polydactyly
|
|
|
|
|
|
|
|
√
|
|
mortality/aging
|
|
√
|
√
|
√
|
√
|
√
|
|
|
|
|
lethality throughout fetal growth and development, complete penetrance
|
|
|
|
|
|
√
|
|
|
|
|
embryonic lethality during organogenesis, complete penetrance
|
|
√
|
√
|
|
|
|
|
|
|
|
preweaning lethality, incomplete penetrance
|
|
|
|
√
|
√
|
|
|
|
|
muscle
|
|
|
|
|
|
√
|
|
|
|
|
thin myocardium
|
|
|
|
|
|
√
|
|
|
|
|
decreased fetal cardiomyocyte proliferation
|
|
|
|
|
|
√
|
|
|
|
normal phenotype
|
√
|
|
|
|
|
|
|
|
|
|
no abnormal phenotype detected
|
√
|
|
|
|
|
|
|
|
|